A novel ratiometric fluorescence assay for cerebral Cu 2+ has been developed based on coumarin-labeled single-stranded DNA coupled with the Cu 2+ -induced oxidation of o -phenylenediamine.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: